These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 5767879)

  • 1. The changes of the tissue plasminogen activator levels in the endometrium during antifibrinolytic therapy.
    Koutský J; Rybák M; Jirásek JE; Hladovec J; Mansfeld V
    Gynaecologia; 1969; 167(4):265-70. PubMed ID: 5767879
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antifibrinolytic therapy of gynecologic hemorrhages (literature survey)].
    Skipetrov VP
    Akush Ginekol (Mosk); 1974 Oct; (10):1-6. PubMed ID: 4280255
    [No Abstract]   [Full Text] [Related]  

  • 3. Biphasic inhibition of urokinase-induced fibrinolysis by epsilon-aminocaproic acid; distinction from tissue plasminogen activator.
    Thorsen S; Astrup T
    Proc Soc Exp Biol Med; 1969 Mar; 130(3):811-3. PubMed ID: 5773672
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of urokinase and tissue activator in sustaining bleeding and the management thereof with EACA and AMCA.
    Andersson L; Nilsoon IM; Colleen S; Granstrand B; Melander B
    Ann N Y Acad Sci; 1968 Jun; 146(2):642-58. PubMed ID: 5254275
    [No Abstract]   [Full Text] [Related]  

  • 5. Histochemical study of the changes in endometrial fibrinolytic activity during treatment of menometrorrhagia with anitfbrinolytics.
    Koutský J; Jirásek JE
    Gynaecologia; 1969; 168(4):241-7. PubMed ID: 5310095
    [No Abstract]   [Full Text] [Related]  

  • 6. Antifibrinolytics gynaecology and obstetrics.
    Koutský J; Hladovec J
    Acta Univ Carol Med (Praha); 1975; 21(5-6):235-386. PubMed ID: 132853
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of a new potent antifibrinolytic agent, tranexamic acid.
    Kobayashi T; Sugiura J
    J Jpn Obstet Gynecol Soc; 1966 Jul; 13(3):158-67. PubMed ID: 5341162
    [No Abstract]   [Full Text] [Related]  

  • 8. The content of plasminogen-activator in the endometrium, estimated by the fibrin-agar plate method.
    Koutský J; Rybák M; Jirásek JE; Hladovec J
    Gynaecologia; 1969; 167(4):257-64. PubMed ID: 4889672
    [No Abstract]   [Full Text] [Related]  

  • 9. [Substances inhibiting fibrinolysis].
    Lakin KM; Rachitskaia NG; Gavrilov AP
    Kardiologiia; 1972 Apr; 12(4):139-53. PubMed ID: 4558033
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthetic inhibitors of fibrinolysis: in vitro and in vivo mode of action.
    Okamoto S; Oshiba S; Mihara H; Okamoto U
    Ann N Y Acad Sci; 1968 Jun; 146(2):414-29. PubMed ID: 5254270
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative activities of amino acid and polypeptide inhibitors on natural and synthetic substrates.
    Skoza L; Tse AO; Semar M; Johnson AJ
    Ann N Y Acad Sci; 1968 Jun; 146(2):659-72. PubMed ID: 4239440
    [No Abstract]   [Full Text] [Related]  

  • 12. Tranexamic acid and fibrinolytic activity of the vessel wall.
    Astedt B; Liedholm P
    Experientia; 1974 Jul; 30(7):776-7. PubMed ID: 4847668
    [No Abstract]   [Full Text] [Related]  

  • 13. Fibrinolysis and its control.
    Andersson L
    S Afr Med J; 1972 Feb; 46(8):182-5. PubMed ID: 4260535
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of tranexamic acid (AMCA) on postoperative bleeding after conization.
    Rybo G; Westerberg H
    Acta Obstet Gynecol Scand; 1972; 51(4):347-50. PubMed ID: 4566005
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antifibrinolytic and antihemorrhagic activity of trans-aminomethyl cyclohexane carboxylic acid (AMCHA). Clinical experience].
    Avanzi G
    Minerva Med; 1972 Dec; 63(87):4758-66. PubMed ID: 4565687
    [No Abstract]   [Full Text] [Related]  

  • 16. Pregnancy complicated by plasminogen activator inhibitor type 1 deficiency.
    Smith C; Thornton YS
    South Med J; 2010 Dec; 103(12):1259-60. PubMed ID: 21037516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative assessment of fibrinolysis on isolated glomeruli.
    Sraer JD; Boelaert J; Mimoune O; Morel-Maroger L; Hornych H
    Kidney Int; 1973 Nov; 4(5):350-2. PubMed ID: 4762582
    [No Abstract]   [Full Text] [Related]  

  • 18. [Contrykal as antifibrinolytic agent in obstetrics and gynecology].
    Flähmig M; Sieg U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):142-50. PubMed ID: 4174652
    [No Abstract]   [Full Text] [Related]  

  • 19. [The pattern of fibrinolytic disorders in uterine blood and the effect of PAMBA]].
    Flähmig M; Sieg U; Vogel G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 87(1):41-50. PubMed ID: 4173879
    [No Abstract]   [Full Text] [Related]  

  • 20. Massive bleeding with fibrinolysis: management with heparin and epsilon aminocaproic acid.
    Bergin JJ; Crosby WH; Jahnke EJ
    Mil Med; 1966 Apr; 131(4):340-4. PubMed ID: 4955920
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.